Table 3.
Cooccurrence of genotypes CYP3A5 and C3435T MDR1 and drug resistance in epilepsy.
Cooccurrence of CYP3A5 versus MDR1 | Number of patients | Comparison group | |
---|---|---|---|
Drug resistant [100%] | Drug sensitive [100%] | ||
1.3 versus CC | 0 | 0 | NS |
1.3 versus CT | 17.7% | 22.2% | |
1.3 versus TT | 5.9% | 0 | |
3.3 versus CC | 17.7% | 0 | |
3.3 versus CT | 52.8% | 44.4% | |
3.3 versus TT | 5.9% | 33.4% |
NS: not statistically significant.